What’s New in Antiretroviral Safety and Tolerability: Implications for Treatment

Download All
In this comprehensive online program led by expert faculty, review clinical strategies for applying the latest safety and tolerability data to minimize adverse events when selecting first-line ART and switching regimens in patients with HIV infection.
Kassem Bourgi, MD

Clinical Focus

In this case-based, focused activity, review the latest data from 2020 scientific meetings on weight gain, cardiometabolic endpoints, and pregnancy outcomes with current ART regimens.

Kassem Bourgi, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: August 11, 2020 Expired: No longer available for credit
Provided by USF Health

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Janssen Therapeutics, Division of Janssen Products, LP

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings